Connect with us

Press Release

What’s the NFT game Tencent & Alibaba Rush into?

Published

on

In June 2021, Alibaba and Dunhuang Arts Institute jointly released two NFTs, Dunhuang Flying Sky and Nine Color Deer App skins, which were limited to 16,000 in the world. The works were looted as soon as they were released.

On June 26, 2021, NetEase and Nervina Labs released their first NFT work on Taobao.

On August 3, 2021, Chinese tech giant Tencent’s  NFTs trading platform -Huanhe launched 300 copies “Vinyl Record NFT” authorized by TV program “Thirteen Invitations”, and sold out instantly.

Chinese giants’ capital is vying to chase, and it’s so fierce. So far people can’t help asking, what is NFT?

Meet NFT

NFT is short for Non-fungible Token,which is relative to the concept of Fungible Token (FT), each NFT has a unique and only identification, which is not interchangeable, and the smallest unit is 1 and indivisible.

Generally, BTC, ETH, etc. we familiar with are Fungible Token. For example, BTC everyone owns is same, it’s interchangeable with each other, can also be divided into 0.1, or 0.01 without affecting the value and use.

NFT represents indivisible and non-interchangeable items in reality, such as a real estate certificate, a famous painting, a piece of game equipment and so on. They are all unique, and completely lose their value and practicality after being divided. The most typical are collectibles and artworks. These products with non-fungible genes are digitized and tokenized using blockchain technology, and they have become popular NFTs today.

NFT is one and only

Economics stipulates that currency is a unity equivalent and a carrier of consensus on value. In modern society, personal wealth is no longer measured by currency holdings, but includes the value and quantity of assets under his name. Its assets include but not limited to items with market value such as houses, cars, stocks, etc. In most case, the value carried by an asset often far exceeds the value of the cash value they hold. However, real assets have two major shortcomings: poor liquidity and high cost of confirmation. For example, the determination of the right of a house needs to rely on the registration of the Housing Management Committee to determine the ultimate ownership of the house.

But in the blockchain world, the assets we currently have are BTC, ETH with currency attributes. After meeting demand for monetary assets, a value medium of non-monetary assets will naturally emerge, and this is NFT. Relying on the decentralization, immutability and cryptographic authentication of the blockchain, NFT solves a series of problems of real assets:

• The asset is unique and cannot be faked

• Strong liquidity, real-time trading;

• Cryptography is the confirmation and cannot be tampered with.

In addition, NFT also has features that cryptocurrency does not have. Its unique features can be used for identity certification, item ownership certification, virtual props, etc. NFT makes crypto assets more practical, enabling users to expand the utilization of valuable assets in the form of NFT, and is protected by blockchain technology.

NFT Boom Out

NFT is not a new thing born this year, it has made any public appearances early in 2017, but more regarded as a niche thing within Ethereum.

So, what is the real important promoter of NFT out of the circle?

First, let’s ask a question: How much would a digital picture be? The answer is $69.3 million!

On March 11, 2021, an unknown artist Beeple collaged his daily art work for the past thirteen years into a digital picture called “everyday: the first 5000 days”. At Christie’s, it was sold for $69.3 million, which shocked the world.

Overnight, NFT became the outlet. This 40-year-old American painter also made great fortune overnight. The popularity of NFT has caused a huge sensation in many fields such as art, venture capital, and finance.

Commercial filed such as NBA, Samsung, McDonald’s, Marvel, movie stars, etc. are all releasing their own NFT products, and venture capital industry such as Three Arrows Capital, Signum Capital, NGC Ventures, Coinbase, etc. have begun to invest in this field. Internet giants such as Tencent, JD, Facebook, Twitter, etc. are all laying out the NFT battlefield. The opportunities and challenges brought by NFT are more than that brought by the mobile Internet to the Internet.

From the perspective of business history, iPhone, Amazon, Microsoft, etc. were initially used by industry insiders. After going out of the circle by marketing, products, and the trend of the times, the entire society began to accept them, and they evolved from product for a specific group into mass infrastructure. Although the development of NFT is still at an early stage, the boom out of NFT will continue the historical trajectory and accelerate the application of blockchain technology. It is of great significance for promoting the digitalization of society.

NFT Bright Future

Except crypto artworks, will NFT have wider applications? We can find that NFT will be widely used in the future. For example, the recent popular NFT+DeFi and NFT+game, as well as the concept of meta-universe, are inseparable from the future development of NFT. The physical application of NFT will solve many problems for the society, such as: 

First, intellectual property. NFT can represent a painting, a song, a patent, a film, a photo, or other intellectual property rights. NFT can help each unique thing to register the copyright and help it identify the patent.

Second, physical assets. Real estate such as houses and other physical assets are digitized through NFT. It can be used in financial markets such as the circulation of assets.

Third, records and identification. The unique features of NFT, can be used to verify identity and birth certificates, driver’s licenses, academic certificates, etc., to prevent abuse or tampering.

There will be many physical applications of NFT in the future, which will surely solve various practical problems for the society. Presumably this is the ultimate goal of various giant capitals. As the world’s first physical digital economy token trading platform-BtLux Exchange focuses on the implementation of blockchain scenarios that are closely related to people’s lives.

Different from other cryptocurrencies with no entity value support, BtLux regards the underlying innovation of the blockchain as an important breakthrough in the independent innovation of core technology, and takes the use of blockchain to trade, calculate, and record to promote real economic activities on the chain under supervision. At the same time, realize the market operation and value management of digital assets after the certification, redefine the interest distribution relationship of producers, consumers and participants, and form a brand new financial and business model.

Soon, BtLux will accelerate the integration of NFT and physical enterprises based on years of experience in the implementation of blockchain physical scenarios, provide top-level business architecture design and digital economic model design for physical enterprises, and jointly build “blockchain” + “new ecology”, So that participants in the entire chain can benefit. It would bring tangible benefits to the real economy and the entire society, and be widely recognized by the society, making digital currency a living water, flowing in the real economy, and bringing benefits to the real economy more vitality and new power.

NFT is a new world brought about by the technological explosion era, and the digitalization process of the real world in the next ten years will also be greatly accelerated. In the future, only when NFT accelerates the deep integration of the real economy and the digital economy, the technological value of the blockchain will gradually emerge in this process. It will be able to bring new business models and reconstruct distribution models, market structures, organizational forms, and industry relationships to promote human beings to a new era of digital civilization, and in that, BtLux will become an indispensable promoter.

BtLux Official website: https://www.btlux.top/

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

FS-Elliott to Be Featured on Now We Know with Steve Guttenberg Airing March 14 on CNBC

Published

on

Export, PA, United States, 13th Mar 2026 – The upcoming episode of Now We Know! with Steve Guttenberg, airing March 14, 2026 at 1pm ET on CNBC will feature FS-Elliott, a company specializing in the design and manufacturing of high-performance centrifugal air and gas compressors.

The segment provides viewers with a behind-the-scenes look at the engineering and precision required to produce industrial equipment that supports manufacturing, energy production, and critical infrastructure worldwide. Through advanced technology and meticulous design, FS-Elliott’s compressors help power operations across a wide range of industries.

From reliability and efficiency to long-term performance, the episode highlights the role that specialized equipment plays in keeping industrial systems running smoothly.

By showcasing FS-Elliott’s work, Now We Know! sheds light on the often-unseen technologies that support modern industry. The series continues its mission to reveal the innovation and expertise behind the systems that drive everyday life.

About Now We Know!

Hosted by actor, author, and businessman, Steve Guttenberg, this unique platform inspires the next generation of knowledge seekers and viewers around the country. Each episode features up to four industry experts who provide their own unique perspective on the topic at hand via a 6-8–minute segment produced by our team, bringing a fresh look at interesting narratives, moderated by the one and only Steve Guttenberg. 

Learn more at NowWeKnowTV.com

About FS-Elliott Co., LLC

FS-Elliott is a global leader in the engineering and manufacturing of oil-free, centrifugal air and gas compressors, with operations in over 90 countries. For over 60 years, FS-Elliott has combined a commitment to quality with advanced technology, enabling our customers to increase productivity and lower system operating costs. For more information, visit www.fs-elliott.com.

For more details, contact:

Now We Know! with Steve Guttenberg

(877) 546-9995

feature@nowweknowtv.com

nowweknowtv.com

SOURCE Now We Know! with Steve Guttenberg

All images courtesy of Now We Know! with Steve Guttenberg

 

Media Contact

Organization: Now We Know!with Steve Guttenberg

Contact Person: Media Relations

Website: https://nowweknowtv.com/

Email: Send Email

Contact Number: +18775469995

City: Export

State: PA

Country:United States

Release id:42579

The post FS-Elliott to Be Featured on Now We Know with Steve Guttenberg Airing March 14 on CNBC appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China

Published

on

SHENZHEN, CHINA China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that on 13 March 2026, new drug for renal anaemia Desidustat Tablets (the “Product”) has been approved for marketing in China by the National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a novel, oral HypoxiaInducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in non-dialysis adult, Chronic Kidney Disease (CKD) patients.

The approval of Desidustat Tablets will further strengthen the Group’s overall layout in the field of nephrology, and synergize with the marketed innovative drug Velphoro (Sucroferric Oxyhydroxide Chewable Tablets, indicated for CKD hyperphosphatemia). Through the efficient linkage of nephrology expert resources and channel networks, the Group is expected to rapidly promote the large-scale clinical application of Desidustat Tablets, providing differentiated treatment options for Chinese CKD patients with renal anaemia and making a positive contribution to the Group’s performance.

More information about Desidustat Tablets and Renal Anaemia

As a novel oral HIF-PHI, the Product’s mechanism of action promotes erythropoiesis through increasing endogenous erythropoietin, improving iron availability and reducing hepcidin. Its China Phase III clinical trial has demonstrated positive results. The primary endpoint of the haemoglobin (Hb) mean change from baseline to Week 7-9 has indicated that, Desidustat is more effective than placebo in increasing Hb level. Results from the extension study demonstrate that the Product can maintain Hb level within the target range over the long term with acceptable safety. In addition, the Product significantly reduces hepcidin levels and ameliorates iron metabolism disorders.

There is still a large unmet need in the treatment of anaemia in CKD patients in China. It is estimated that there are more than 120 million CKD patients in China[1]. Anaemia is one of the frequent complications of CKD, which exhibits a progressively increasing incidence with disease progression. A survey in China showed that the prevalences of anaemia in patients at CKD stage 1 to 5 were 22.0%, 37.0%, 45.4%, 85.1%, and 98.2%, respectively[2]. The target-achieving rate (the Hb level reaching the target value (110~120g / L)) has increased to 51.5% for haemodialysis CKD patients with anaemia[3], but is still only 8.2% for anaemia patients in non-dialysis CKD[4]. The Product is administrated orally, thus expecting to improve the treatment compliance of patients and to meet the unmet treatment needs in the field of CKD anaemia.

Desidustat Tablets have been approved for marketing in India.

CMS INTERNATIONAL DEVELOPMENT AND MANAGEMENT LIMITED, a wholly-owned subsidiary of the Group, obtained an exclusive license for the Product from Zydus Lifesciences Limited (earlier known as Cadila Healthcare Limited) pursuant to a License Agreement with an effective date of 20 January 2020.

The Group adheres to its core strategy of “innovation-driven”, having established a tiered and multi-dimensional innovation product portfolio with abundant reserves: 7 new drugs have been approved for marketing, 6 are currently under marketing review, and nearly 20 projects are about to initiate or are progressing through clinical trials. Through a dual-engine innovation approach combining collaborative development and in-house R&D, the Group continuously enriches its innovative pipeline centered on first-in-class (FIC) and best-in-class (BIC) products, efficiently advancing clinical development and commercialization. Moving forward, CMS will remain clinical needs-driven to deliver more quality pharmaceutical solutions, steadfastly advancing toward the goal of becoming a specialty-focused, innovation-excellent multinational pharmaceutical enterprise.

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the Cardiovascular-Kidney-Metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

Reference

1. ZhangL, WangF, WangL, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. DOI: 10.1016/S0140-6736(12)60033-6

2. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2014 Revised Edition)[J]. Chinese Journal of Nephrology, 2014, 30(9): 712-716. DOI: 10.3760/cma.j.issn.1001-7097.2014.09.015

3. 19th CSN Critical Care & Blood Purification Congress, Chinese Medical Association (July 2-5, 2025)

4. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2018 Revised Edition)[J]. Chinese Journal of Nephrology, 2018, 34(11): 860-866. DOI: 10.3760/cma.j.issn.1001-7097.2018.11.012

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

 

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Website: https://web.cms.net.cn/en/home/

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Healing Beyond Surgery: Paramedical Tattooing Takes the Stage at Gather and Grow Cancer Event in Scottsdale

Published

on

Scottsdale, AZ April 11, 2026 At the upcoming Gather and Grow conference, nationally recognized paramedical tattoo specialist Jayd Hernandez will lead an educational session highlighting how restorative tattooing is helping cancer survivors reclaim confidence, identity, and a sense of self after treatment.

Hernandez will present Transformative Tattooing: Restoring Identity Through Paramedical Art on Saturday, April 11, 2026, from 12:30 to 1:00 PM MST at the Hotel Valley Ho in Scottsdale.

The session explores how paramedical tattooing, including hyper realistic 3D areola restoration and scar camouflage, extends healing beyond surgery. Blending medical precision with artistic care, this specialized practice supports emotional recovery and body confidence for individuals navigating life after cancer.

Hernandez is a nationally recognized expert in 3D areola and nipple tattooing, specializing in hyper realistic restoration for breast cancer survivors following mastectomy. With more than a decade of experience and over 1,000 restorative procedures performed, her work is known for delivering results that are both visually lifelike and emotionally restorative.

She holds a National Provider Identifier, allowing eligible patients to pursue medical reimbursement for their procedures. Her trauma informed process and advanced aesthetic technique have led many reconstructive surgeons to refer patients directly to her studio for final stage care.

As the founder of one of the industry’s most comprehensive paramedical tattoo training programs, Hernandez has also trained a new generation of artists in medically responsible, client centered care. Her work has been recognized across both medical and beauty communities, helping bridge the gap between aesthetics and post surgical aftercare.

In addition to her presentation at Gather and Grow, Hernandez will attend the Oncology Clinical Updates Review and Renew in Sedona on April 11 and 12, 2026, where she has been invited as an Honorarium Attendee, reflecting growing recognition of her expertise within oncology adjacent and medical aesthetics communities.

Later this month, Hernandez is also scheduled to appear as a panel speaker on beauty business ownership at the Aveda Institute Phoenix, contributing her perspective on entrepreneurship within the beauty industry.

The Gather and Grow event brings together professionals, educators, and advocates focused on innovation, healing, and patient centered care in the cancer community.

For more information, visit:

https://jaydhernandez.com/

Media Contact

Organization: Jayd Hernandez

Contact Person: Jayd Hernandez

Website: https://jaydhernandez.com/

Email: Send Email

Contact Number: +14805765230

Country:United States

Release id:42543

The post Healing Beyond Surgery: Paramedical Tattooing Takes the Stage at Gather and Grow Cancer Event in Scottsdale appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST